TCL Archive NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer August 26, 2005
TCL Archive FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma. February 17, 2006
TCL Archive As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray December 13, 2002